)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Plus Therapeutics
Plus Therapeutics (PSTV) investor relations material
Plus Therapeutics Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary9 Jan, 2026
Company overview and business model
Develops targeted radiotherapeutics and advanced diagnostics for central nervous system (CNS) cancers, including glioblastoma, leptomeningeal metastases, and pediatric brain cancers.
Lead product REYOBIQ™ is a radiotherapeutic for CNS cancers, delivered via localized methods to maximize tumor dose and minimize healthy tissue exposure.
CNSide Diagnostics subsidiary commercializes the CNSide® CSF Tumor Cell Enumeration test for detecting and monitoring CNS metastases.
Recent expansion into diagnostics with the acquisition and relaunch of the CNSide Platform.
Financial performance and metrics
Incurred net losses of $13.0 million in 2024 and $16.7 million for the nine months ended September 30, 2025.
Accumulated deficit of $510.2 million as of September 30, 2025.
Cash and cash equivalents of $13.3 million as of September 30, 2025; working capital of $4.0 million.
Grant revenue recognized from CPRIT: $5.8 million in 2024 and $3.8 million for the nine months ended September 30, 2025.
Ongoing need for additional capital to fund operations and clinical programs.
Use of proceeds and capital allocation
Estimated net proceeds from the offering are $10.9 million (up to $12.7 million if the over-allotment is exercised).
Proceeds intended for working capital and general corporate purposes, including R&D, regulatory, and commercialization activities.
Management has broad discretion over use of proceeds; may also use funds for acquisitions or investments in complementary businesses.
Assess sufficiency of recent capital raises for 12-month operations
How does the LDT rule vacating impact CNSide strategy?
Given limited resources, how are pipeline candidates prioritized?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Plus Therapeutics earnings date
Q4 202512 Mar, 2026
Plus Therapeutics
Next Plus Therapeutics earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative therapies for rare cancers. The company leverages nanotechnology and targeted drug delivery platforms to design precision treatments, including radiotherapeutics for central nervous system cancers and other challenging oncological conditions. The company is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage